Sepsis-Induced Muscle Proteolysis Is Prevented by a Proteasome Inhibitor in Vivo
- 2 April 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 270 (1) , 215-221
- https://doi.org/10.1006/bbrc.2000.2398
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Gene Expression of Ubiquitin Ligase E3α Is Upregulated in Skeletal Muscle during Sepsis in Rats—Potential Role of GlucocorticoidsBiochemical and Biophysical Research Communications, 2000
- The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancerSurgery, 1999
- Cardioprotective Effects of a Novel Proteasome Inhibitor Following Ischemia and Reperfusion in the Isolated Perfused Rat HeartJournal of Molecular and Cellular Cardiology, 1999
- Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in ratsClinical Science, 1998
- THE UBIQUITIN SYSTEMAnnual Review of Biochemistry, 1998
- Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.Journal of Clinical Investigation, 1997
- N-Acetyl-leucinyl-leucinyl-norleucinal Inhibits Lipopolysaccharide-Induced NF-κB Activation and Prevents TNF and IL-6 Synthesisin VivoCellular Immunology, 1997
- Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle.Journal of Clinical Investigation, 1997
- Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle.Journal of Clinical Investigation, 1994
- A New Inhibitor of the Chymotrypsin‐Like Activity of the Multicatalytic Proteinase Complex (20S Proteasome) Induces Accumulation of Ubiquitin‐Protein Conjugates in a Neuronal CellJournal of Neurochemistry, 1994